SST and cancer: SST analogs such as Octreotide and Lanreotide are currently used for the treatment of multiple diseases, including certain cancers (particularly neuroendocrine tumors), which supports a role for SST in downregulating pro-tumorigenic processes in the pancreas (Enzler and Fojo, 2017).